Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Economic evaluation for the United Kingdom (UK) of systemic chemotherapies as first-line treatment for metastatic pancreatic cancer (MPC)

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: ABRAHAM, Ivo (UNIVERSITY OF ARIZONA, Pharmacy Practice and Science, Tucson, United States)
  • Co-author(s): Mahdi Gharaibeh:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States|Ivo Abraham:Center for Health Outcomes and PharmacoEconomic Research,UNIVERSITY OF ARIZONA,Tucson,United States;Arizona Cancer Center,UNIVERSITY OF ARIZONA,Tucson,United States
  • Abstract:

    NAB-P+GEM and FFX have shown superior survival efficacy over GEM alone as first-line treatment for MPC. Meta-analysis showed Statistical significant improvement in OS detected especially with CIS+GEM, CAP+GEM, or OX+GEM. 

    We used published direct and indirect efficacy estimates of FOLFIRINOX v. other regimens from published network meta-analysis. A

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses